Accordingly, inhibition of CYP3A4 by clarithromycin or shRNA-mediated knockdown reversed the stromal-mediated protection of MM cells against dexamethasone (Figure 2B). The gene discussed is CYP3A4; the disease is Miyoshi myopathy.